CN106902225A - 一种治疗灰指甲的中药制剂 - Google Patents
一种治疗灰指甲的中药制剂 Download PDFInfo
- Publication number
- CN106902225A CN106902225A CN201510949437.4A CN201510949437A CN106902225A CN 106902225 A CN106902225 A CN 106902225A CN 201510949437 A CN201510949437 A CN 201510949437A CN 106902225 A CN106902225 A CN 106902225A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- root
- medicine preparation
- onychomycosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000010195 Onychomycosis Diseases 0.000 title claims abstract description 26
- 201000005882 tinea unguium Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 13
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 12
- 240000002234 Allium sativum Species 0.000 claims abstract description 11
- 241000050051 Chelone glabra Species 0.000 claims abstract description 11
- 241000931143 Gleditsia sinensis Species 0.000 claims abstract description 11
- 244000241872 Lycium chinense Species 0.000 claims abstract description 11
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 11
- 241000132171 Phryma leptostachya Species 0.000 claims abstract description 11
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 11
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 11
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 11
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 11
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 11
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 11
- 235000004611 garlic Nutrition 0.000 claims abstract description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000558306 Gynocardia odorata Species 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 abstract description 15
- 241000233866 Fungi Species 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 230000008030 elimination Effects 0.000 abstract description 3
- 238000003379 elimination reaction Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000000282 nail Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241001480043 Arthrodermataceae Species 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000037304 dermatophytes Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000001699 lower leg Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000000431 third toe Anatomy 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000004906 toe nail Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241001179022 Hydnocarpus anthelminthicus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023138 Jaundice neonatal Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical class ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 201000006346 Neonatal Jaundice Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
- 240000005616 Vigna mungo var. mungo Species 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 229940084434 fungoid Drugs 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- -1 triterpene alkenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000003878 whitfield ointment Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗4-9份、水杨酸4-9份、薄荷冰5-10份、蛇床子3-8份、丁香5-10份、黄芩4-9份、五倍子3-8份、虎杖3-8份、大风子1-3份、地骨皮3-8份、皂角4-9份、透骨草1-3份、枯矾5-10份、川椒1-3份、大蒜1-3份。本发明通过各原料相配,具有对多种真菌很强的杀灭能力,治疗效果好,治愈率为86%以上,总有效率为96%以上,使用方便且彻底根除、无毒副作用。
Description
技术领域
本发明涉及医药领域,具体是一种治疗灰指甲的中药制剂。
背景技术
甲癣,俗称“灰指甲”,是指皮癣菌侵犯甲板或甲下所引起的疾病。甲真菌病是由皮癣菌、酵母菌及非皮癣菌等真菌引起的甲感染。灰指甲的临床表现:1.甲下型甲癣,常从甲板两侧或末端开始,多先有轻度甲沟炎,后来逐渐变成慢性或渐趋消退。甲沟炎可引起甲面有凹点或沟纹,持续不变或渐累及甲根。一旦甲板被感染,即可形成裂纹、变脆或增厚,呈棕色或黑色。本型常见。因甲下角蛋白及碎屑沉积,致甲变松及甲浑浊肥厚。2.真菌性白甲(浅表性白色甲癣),为甲板表面一个或多个小的浑浊区,外形不规则,可逐渐波及全甲板,致甲面变软、下陷。无任何症状,无甲沟炎,常于甲床皱襞皮肤处见有脱屑。3.白色念珠菌引起的甲癣,多见于家庭主妇、炊事员及经常接触水的人。多合并甲沟炎,起于两侧甲皱襞,可有皮肤红肿、积脓、压痛。附近的甲变为暗色,高起,并于其下的甲床分离,其后整个甲板波及。
灰指甲的治疗通常采取以下几种方式:一是手术拔甲。创面大,易感染,易出血,这种方法创面大,出血,易引起感染。手术后一般会感觉较疼痛,由于“治标不治本”,一般治疗不太理想,容易重新感染复发;患有心脏病、高血压、糖尿病等的患者,不宜进行手术治疗。二是内服药物。单纯服用抗真菌药物有一定疗效,且方便。但因为这类药必须达到真菌所寄生的甲板处才能发挥抗菌作用,而且在水中的溶解度低且慢,吸收代谢又很快,所以用药量大,用药时间长。另外,口服药均有副作用,且停药后易复发,故不宜作为灰指甲的常规治疗药物。三是外用疗法。根据药剂不同,主要有局部涂药和封包削治等方法。治疗时需配合去除病甲,故一般没有内服法方便,但却安全、无痛苦、无副作用。如复方苯甲酸软膏或擦剂、咪康唑类霜剂、亮甲、达克宁、脚癣一次净等,但疗效较低,易复发,价格较高。因此,对灰指甲的治疗没有特效药。
发明内容
本发明的目的在于提供一种治疗效果好、使用方便、彻底根除、无毒副作用的治疗灰指甲的中药制剂,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗4-9份、水杨酸4-9份、薄荷冰5-10份、蛇床子3-8份、丁香5-10份、黄芩4-9份、五倍子3-8份、虎杖3-8份、大风子1-3份、地骨皮3-8份、皂角4-9份、透骨草1-3份、枯矾5-10份、川椒1-3份、大蒜1-3份。
作为本发明进一步的方案:所述治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗5-7份、水杨酸5-7份、薄荷冰6-9份、蛇床子4-6份、丁香6-8份、黄芩5-8份、五倍子5-6份、虎杖5-6份、大风子2份、地骨皮5-6份、皂角6-8份、透骨草2份、枯矾7-8份、川椒2份、大蒜2份。
本发明中荆芥穗解表散风,透疹,消疮。用于感冒,头痛,麻疹,风疹,疮疡初起。
水杨酸是一种脂溶性的有机酸。水杨酸(阿司匹林以及很多止痛药里的成分)在临床试验上用来降低糖尿病患者长期并发心脏病的风险。
薄荷冰主要刺激皮肤粘膜,在止痒、消炎、止痛的同时,局部具有凉感。临床用于疼痛,炎症及肿胀。也可内服治疗头痛、鼻炎、咽炎和喉炎。
蛇床子温肾壮阳,燥湿,祛风,杀虫。用于阳痿、宫冷、寒湿带下、湿痹腰痛;外治外阴湿疹、妇人阴痒、滴虫性阴道炎。
丁香有温中降逆,补肾助阳的功效。用于脾胃虚寒,呃逆呕吐,食少吐泻,心腹冷痛,肾虚阳痿。
黄芩有清热燥湿、泻火解毒、止血、安胎等功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。
五倍子具有敛肺降火,涩肠止泻,敛汗,止血,收湿敛疮之功效。常用于肺虚久咳,肺热痰嗽,久泻久痢,自汗盗汗,消渴,便血痔血,外伤出血,痈肿疮毒,皮肤湿烂。
虎杖具有利湿退黄,清热解毒,散瘀止痛,止咳化痰的功效。用于湿热黄疸,淋浊,带下,风湿痹痛,痈肿疮毒,水火烫伤,经闭,症瘕,趺打损伤,肺热咳嗽。
大风子祛风,功毒,杀虫。用于麻风;外用治疥、癣。
地骨皮具有凉血除蒸、清肺降火等功效。
皂角含三萜皂甙(皂荚甙、皂荚皂甙)、鞣质、蜡醇、廿九烷、豆甾醇、谷甾醇等。有祛痰、开窍的功能。所含有的皂苷素是三萜烯类和低聚糖,有消炎、抗溃疡、抗病变效果,还有抗癌和提高艾滋病免疫力等功效。
透骨草有活血化瘀、利尿解毒、通经透骨之功效。鲜草捣烂外敷,可治疮疖肿疼、毒虫咬伤。
枯矾消痰,燥湿,止泻,止血,解毒,杀虫。治癫痫,喉痹,疚涎壅甚,肝炎,黄疸,黄肿,胃、十二指肠溃疡,子宫脱垂,白带,泻痢,衄血,口舌生疮,疮痔疥癣,水、火、虫伤。
川椒温中止痛,杀虫止痒。用于脘腹冷痛,呕吐泄泻,虫积腹痛;外治湿疹,阴痒。
大蒜具有解毒消肿,杀虫,止痢之功效。常用于痈肿疮疡,疥癣,肺痨,顿咳,泄泻,痢疾。
与现有技术相比,本发明的有益效果是:
本发明通过各原料相配,具有对多种真菌很强的杀灭能力,治疗效果好,治愈率为86%以上,总有效率为96%以上,使用方便且彻底根除、无毒副作用。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本发明实施例中,一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗4份、水杨酸4份、薄荷冰5份、蛇床子3份、丁香5份、黄芩4份、五倍子3份、虎杖3份、大风子1份、地骨皮3份、皂角4份、透骨草1份、枯矾5份、川椒1份、大蒜1份。
实施例2
本发明实施例中,一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗9份、水杨酸9份、薄荷冰10份、蛇床子8份、丁香10份、黄芩9份、五倍子8份、虎杖8份、大风子3份、地骨皮8份、皂角9份、透骨草3份、枯矾10份、川椒3份、大蒜3份。
实施例3
本发明实施例中,一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗5份、水杨酸5份、薄荷冰6份、蛇床子4份、丁香6份、黄芩5份、五倍子5份、虎杖5份、大风子2份、地骨皮5份、皂角6份、透骨草2份、枯矾7份、川椒2份、大蒜2份。
实施例4
本发明实施例中,一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗7份、水杨酸7份、薄荷冰9份、蛇床子6份、丁香8份、黄芩8份、五倍子6份、虎杖6份、大风子2份、地骨皮6份、皂角8份、透骨草2份、枯矾8份、川椒2份、大蒜2份。
实施例5
本发明实施例中,一种治疗灰指甲的中药制剂,按照重量份的原料包括:荆芥穗6份、水杨酸6份、薄荷冰7份、蛇床子5份、丁香7份、黄芩6份、五倍子5.5份、虎杖5.5份、大风子2份、地骨皮5.5份、皂角7份、透骨草2份、枯矾7.5份、川椒2份、大蒜2份。
将上述实施例中各中药的原料混合后研磨成粉即可。
实施例6 临床试验
本发明药物治疗灰指甲的临床观察
1、病例选择:选择根据症状和医院检查确诊为灰指甲的患者为观察对象。试验1-5组分别采用本发明实施例1-5药物制得的中药制剂进行治疗。试验组共250例,每组50例。各组病例的病程、症状轻重程度等,综合平均后无显著性差异,各组之间有可比性。
2、治疗方法:试验1-5组每晚洗净患处,将药膏均匀地涂抹在病甲表面用药物涂覆,用“创可贴”封住,保持10小时,10天为一疗程,连续使用本发明两个疗程。
3、诊断标准:
治愈:生出新指甲,真菌镜检阴性。
有效:灰指甲部分减少,真菌镜检阴性。
无效:症状部分减轻,真菌镜检阳性。
4、治疗结果如表1所示
表1
组别 | n | 治愈 | 有效 | 无效 | 治愈率% | 总有效率% |
试验1组 | 50 | 28 | 20 | 2 | 56 | 96 |
试验2组 | 50 | 29 | 20 | 1 | 58 | 98 |
试验3组 | 50 | 33 | 16 | 1 | 66 | 98 |
试验4组 | 50 | 34 | 16 | 0 | 68 | 100 |
试验5组 | 50 | 38 | 12 | 0 | 76 | 100 |
从上表可以看出,试验1-5组的治愈率为86%以上,总有效率为96%以上,有显著性效果。
典型病例:
1、从某,男,53岁,右脚大拇趾甲、二拇趾、中趾及左脚五个趾甲患病5年,经检查确诊为灰指甲,在医院拔过甲,好了两年又复发,用过很多外用药,都不见好转,经常反复;经使用本发明实施例5药物,经过30天的治疗,现趾甲已全部恢复健康,光泽如初。
2、宋某, 男,62岁,左脚大拇趾、二拇趾、无名趾,右脚中趾,右手拇指、食指患病4年,看过很多医院,吃过药,也外用很过药,治疗一段时间好几个,停药了后又都坏,从没有彻底治好过,使用本发明实施例5药物,经过25天按时用药,指甲全部恢复健康。
3、江某, 女,40岁,右脚大拇趾、二拇趾,左脚中趾患病2年,看过很多医院,吃过药,也外用很过药,从没有彻底治好过,使用本发明实施例4药物,经过20天按时用药,指甲全部恢复健康。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (2)
1.一种治疗灰指甲的中药制剂,其特征在于,按照重量份的原料包括:荆芥穗4-9份、水杨酸4-9份、薄荷冰5-10份、蛇床子3-8份、丁香5-10份、黄芩4-9份、五倍子3-8份、虎杖3-8份、大风子1-3份、地骨皮3-8份、皂角4-9份、透骨草1-3份、枯矾5-10份、川椒1-3份、大蒜1-3份。
2.根据权利要求1所述的治疗灰指甲的中药制剂,其特征在于,按照重量份的原料包括:荆芥穗5-7份、水杨酸5-7份、薄荷冰6-9份、蛇床子4-6份、丁香6-8份、黄芩5-8份、五倍子5-6份、虎杖5-6份、大风子2份、地骨皮5-6份、皂角6-8份、透骨草2份、枯矾7-8份、川椒2份、大蒜2份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510949437.4A CN106902225A (zh) | 2015-12-18 | 2015-12-18 | 一种治疗灰指甲的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510949437.4A CN106902225A (zh) | 2015-12-18 | 2015-12-18 | 一种治疗灰指甲的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106902225A true CN106902225A (zh) | 2017-06-30 |
Family
ID=59199392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510949437.4A Pending CN106902225A (zh) | 2015-12-18 | 2015-12-18 | 一种治疗灰指甲的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106902225A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108524887A (zh) * | 2018-05-28 | 2018-09-14 | 陈雨薇 | 一种灰指甲药膏及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536823A (zh) * | 2012-07-13 | 2014-01-29 | 葛学义 | 治疗牛皮癣的外用中药酊剂 |
CN104815257A (zh) * | 2015-05-12 | 2015-08-05 | 孙海辉 | 治疗牛皮癣的外用中药药液 |
-
2015
- 2015-12-18 CN CN201510949437.4A patent/CN106902225A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536823A (zh) * | 2012-07-13 | 2014-01-29 | 葛学义 | 治疗牛皮癣的外用中药酊剂 |
CN104815257A (zh) * | 2015-05-12 | 2015-08-05 | 孙海辉 | 治疗牛皮癣的外用中药药液 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108524887A (zh) * | 2018-05-28 | 2018-09-14 | 陈雨薇 | 一种灰指甲药膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
WO2017206758A1 (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
CN106620539A (zh) | 治疗皮肤病的外用药膏、制备方法及其应用 | |
CN108938800A (zh) | 一种治疗皮肤病涂液膜 | |
CN104096047A (zh) | 一种治疗毒蛇咬伤的外敷解毒软膏及其制备方法 | |
CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
CN102178877A (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN102451348A (zh) | 一种治疗足癣的中药药浴方剂 | |
CN101879267B (zh) | 一种治疗脚鸡眼的复方酊剂 | |
CN103211894A (zh) | 一种治疗刀口创口伤的药物及其制备方法 | |
CN103446240B (zh) | 一种快速愈合伤口的中药组合物 | |
CN103655735B (zh) | 一种治疗脚气、皮肤瘙痒症泡洗剂 | |
CN106902225A (zh) | 一种治疗灰指甲的中药制剂 | |
CN104997890B (zh) | 一种治疗骨折的中药制剂 | |
CN107648444A (zh) | 一种用于外阴脂溢性皮炎的缓释性透皮给药贴 | |
CN107582702A (zh) | 用于中医蜡疗的药蜡组合物及其制备方法 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104127765B (zh) | 一种治疗皮肤癣的滴剂及其制备方法 | |
CN104107373A (zh) | 治疗脚气、脚臭、脚汗的中药 | |
CN104173543B (zh) | 一种治疗失禁性皮炎的中药组合物 | |
CN103977313B (zh) | 一种利湿止痒丸及其制备方法 | |
CN107468870A (zh) | 一种用于治疗皮炎的软膏剂药物及其制备方法 | |
CN106474236A (zh) | 一种治疗皮肤瘙痒的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170630 |